When Innovation and Commercialization Collide: A Patient Advocate View in Neuroblastoma

Subjects

Subjects :

Cancer Research
Cost-Benefit Analysis
MEDLINE
Patient Advocacy
Commercialization
Drug Costs
Neuroblastoma
Antineoplastic Agents, Immunological
Rare Diseases
Drug Development
Gangliosides
Humans
Medicine
Drug Approval
business.industry
Therapies, Investigational
Age Factors
Commerce
medicine.disease
Treatment Outcome
Oncology
Engineering ethics
Immunotherapy
Diffusion of Innovation
business

Details

ISSN :

15277755 and 0732183X

Volume :

40

Database :

OpenAIRE

Journal :

Journal of Clinical Oncology

Accession number :

edsair.doi.dedup.....d5b23bf7e05d0e1934d7d033bd160159